Status:
TERMINATED
Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair
Lead Sponsor:
Jewish Hospital, Cincinnati, Ohio
Conditions:
Post Operative Urinary Retention
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administeri...
Detailed Description
Patients who are scheduled for elective laparoscopic inguinal hernia repair will be consented in the office by the attending physician. An order will be placed during surgery scheduling for tamsulosin...
Eligibility Criteria
Inclusion
- All patients undergoing elective laparoscopic inguinal hernia repair, unilateral or bilateral.
- ≥18 years of age.
- Patients must leave the operating room without at indwelling urinary catheter.
Exclusion
- History of neurogenic bladder requiring routine intermittent catheterization
- Emergent laparoscopic hernia repair.
- Elective laparoscopic hernia repair in conjuncture with an additional operation (e.g. nephrectomy, pelvic surgery) that requires the patient to have a planned, indwelling urinary catheter in the postoperative period.
- Pregnant women.
Key Trial Info
Start Date :
November 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2020
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04434378
Start Date
November 16 2017
End Date
February 5 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jewish Hospital
Cincinnati, Ohio, United States, 45236